Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.282B
Cash
430.7M
Avg Qtr Burn
-47.16M
Short % of Float
1.31%
Insider Ownership
0.26%
Institutional Own.
86.01%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Obicetrapib + ezetimibe Details Dyslipidemia, Hypercholesterolemia | Phase 3 Data readout | |
Obicetrapib Details Heterozygous familial hypercholesterolemia, Atherosclerotic cardiovascular disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Obicetrapib Details Alzheimer's disease | Phase 2a Data readout |